emerging options for t790m-positive acquired resistance
Published 8 years ago • 222 plays • Length 13:53Download video MP4
Download video MP3
Similar videos
-
24:36
treatment options for egfr t790m negative acquired resistance
-
3:24
options for egfr mutation-positive patients with t790m mutation-negative acquired resistance
-
2:10
slcvl raez #17 treatment options for acquired resistance to egfr tkis: t790m-negative disease
-
3:22
what are the choices for egfr mutation-positive ar in patients w/out a t790m mutation?
-
4:26
combinations and other options for acquired resistance in egfr mutation-positive nsclc
-
1:57
slcvl raez #16 treatment options for acquired resistance to egfr tkis: t790m-positive disease
-
3:37
gracecastuc-022_lung_what is an inherited t790m egfr mutation, and what does it mean?
-
3:07
third generation egfr tkis for acquired resistance
-
5:20
rociletinib/osimertinib for egfr t790m-negative nsclc
-
3:22
acquired resistance in lung cancer treatment - lcvl 2024
-
26:27
novel egfr inhibitors in the setting of acquired resistance
-
4:10
3rd generation drug for acquired resistance in egfr lung cancer
-
26:54
what is acquired resistance to targeted therapy, and why does it occur?
-
2:26
patterns of acquired resistance to egfr tkis in egfr mutation-positive nsclc
-
17:45
individual treatments for individual egfr mutations
-
5:09
should a third generation egfr inhibitor be first line therapy for egfr mutation-positive nsclc?
-
18:44
2020 ttf egfr breakout piotrowska part 2 - current options upon acquired resistance to osimertinib
-
7:59
dacomitinib beats iressa as first line treatment for egfr mutation-positive nsclc
-
11:23
2020 ttf egfr breakout piotrowska part 1 - current options upon acquired resistance to osimertinib